secwatch.observer — SEC 8-K summary
======================================

Issuer:     DENTSPLY SIRONA Inc. (XRAY)
CIK:        0000818479
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0000818479-24-000076
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dentsply Sirona suspends Byte aligner sales after FDA consult; Q3 rev ~$951M, impairment up to $550M
--------------------------------------------------------------------------------

- Voluntarily suspends sale/marketing of Byte aligners and impression kits in consultation with FDA.
- Byte represents ~5% of annual revenue; suspension expected to materially impact operations.
- Prelim Q3 net sales ~$951M; adjusted EPS guided $0.49-$0.51 (non-GAAP).
- Expects $450-$550M non-cash goodwill impairment (net of tax) for Orthodontic Aligner and Implant reporting units.
- Q3 sales benefited by ~$20M shift of distributor orders from Q4 due to ERP implementation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818479/000081847924000076/0000818479-24-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818479/000081847924000076/xray-20241024.htm
  HTML page:      https://secwatch.observer/filing/0000818479-24-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer